KE3783A - Water-soluble salts of 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline,compositions containing such salts and the production of such salts
- Google Patents
Water-soluble salts of 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline,compositions containing such salts and the production of such salts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP81305027Aexternal-prioritypatent/EP0051415B1/en
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Publication of KE3783ApublicationCriticalpatent/KE3783A/en
KE378387A1980-10-311987-10-26Water-soluble salts of 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline,compositions containing such salts and the production of such salts
KE3783A
(en)
Water-soluble salts of 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline, compositions containing such salts and the production of such salts
Water-soluble salts of 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline,compositions containing such salts and the production of such salts
The use of dihydro-1h-pyrrolizine-3,5(2h,6h)-dione as a cognition activator, pharmaceutical compositions containing that compound, and the production of such compositions
Water-soluble salts of 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline, compositions containing such salts and the production of such salts
Substituted benzylidenepyrrolo-(2,1-b)quinazolinones and pyrido-(2,1-b)quinazolinones,their preparation and pharmaceutical compositions containing them
Antianginal compositions containing 3-substituted-tetrahydro-pyrrolo(1,2-a)pyrimidinone derivatives and some new 3-substituted-tetrahydro-pyrrolo(1,2-a)pyrimidin-2-ones
Water-soluble salts of 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline,compositions containing such salts and the production of such salts
6,7,8,9-tetrahydro-3h-benz(e)indolamine derivatives, processes for their preparation and intermediates used therein, and pharmaceutical compositions containing the indolamine derivatives